Re: BIO-Europe 11/7

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

tada

Rank: President [?]

Points: 7750 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: BIO-Europe 11/7

in response to

Re: BIO-Europe 11/7

Hartland

posted on Nov 07, 2017 10:46AM

HL - I don't disagree with you. Since we are talking about a private company here, unless they are going to tell us that some BP has offered us an outrageous amount for the company, I don't think it's worth getting my shorts in a knot over.